Significantly lower population-mean levels of GSH in RBCs have been indicated in many disease states including but not limited to: acute exposure to drugs and toxins [1, 2, 3], protein-malnutrition [4], hormonal imbalance [5], genitourinary disease [6], gastrointestinal disease [6], cancer [6], cardiovascular disease [6], musculoskeletal disease [6], Parkinsons disease [7], adult respiratory distress syndrome [8], diabetes mellitus [9, 10], liver disease [11], AIDS [12], cataracts [13], and aging [14, 15]
Proper evaluation, laboratory testing, dosing, and follow-up monitoring remain essential for safety and effectiveness
Frequently Asked Questions What is a growth hormone secretagogue
He has trained over 120 physicians in Anti-Aging and Regenerative Medicine and consulting for their practices
The DAC-modified version binds covalently to albumin in the bloodstream, extending its reported terminal half-life to approximately 68 days, compared with minutes for unmodified GHRH analogues
Pharmacodynamics (PD), pharmacokinetics (PK) and PK-PD modeling of NRF2 activating dietary phytochemicals in cancer prevention and in health
